Dosage, pharmacological effects and clinical outcomes for bivalirudin in percutaneous coronary intervention.
Lui
H K
HK
Cardiac Catheterization Laboratory, Jackson-Madison County General Hospital, Medical Specialties Clinic, 27 Medical Center Drive, Jackson, TN 38301, USA. hklui@aol.com.
D000789:Angina, Unstable / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D000991:Antithrombins / Q000008:administration & dosage*; D018849:Controlled Clinical Trials as Topic; D003328:Coronary Thrombosis / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006629:Hirudins / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy; D010446:Peptide Fragments / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage*; D015912:Thrombolytic Therapy / Q000379:methods
D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin